Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03696368 · ClinicalTrials.gov registry record
The Hoosier Moms Cohort
A clinical trial, sponsored by Indiana University.
- Completed
- Registry status
- 411
- Enrollment target
NCT03696368: Completed study, sponsored by Indiana University.
NCT03696368 is a clinical trial that has completed, run by Indiana University. The registered enrollment target is 411 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03696368 has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- 411 participants
- Enrollment target
Study Summary
The Hoosier Moms Cohort (HMC) study's goal is to better understand the pathophysiology underlying the development of gestational diabetes mellitus (GDM) in pregnant women and its transition to Type 2 diabetes mellitus in mothers and their exposed children. The HMC study wants to determine what biomarkers (genetic, blood based and behavioral/interventional) can be identified in pregnant women affected with GDM and how those biomarkers can be used to impact preventative care.
Primary Outcome
Number of subjects diagnosed with GDM
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 411 participants |
| Start Date | 2019-01-04 |
| Est. Completion | 2023-01-15 |
What the finished NCT03696368 record still lists
NCT03696368 is an observational study that tracks outcomes without assigning an intervention. The registered 411 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT03696368 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03696368 about?
NCT03696368 is a clinical study titled "The Hoosier Moms Cohort". The Hoosier Moms Cohort (HMC) study's goal is to better understand the pathophysiology underlying the development of gestational diabetes mellitus (GDM) in pregnant women and its transition to Type 2 diabetes mellitus in mothers and their exposed children. The HMC study wants to determine what biom...
What is the current status of trial NCT03696368?
This trial is currently completed. The enrollment target is 411 participants. The study started on 2019-01-04. Estimated completion is 2023-01-15.
Who is sponsoring clinical trial NCT03696368?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05993689 · 412 participants · NA
Building TrUst and UNiting Teams Through DouLa partnErship - BUNDLE
- NCT06699212 · 412 participants · Phase 3
A Study of ASP-1929 Photoimmunotherapy in Combination With Pembrolizumab in First-line Treatment of Locoregional Recurrent Squamous Cell Carcinoma of the Head and Neck With No Distant Metastases
- NCT02043691 · 410 participants · NA
Evaluation of the Cook Custom Aortic Endograft, the Zenith t-Branch Endovascular Graft, and Surgeon-Modified Endograft in Treating Aortic Pathologies
- NCT03042975 · 410 participants
Imaging Genetics of Laryngeal Dystonia
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI